Literature DB >> 17891513

Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia.

Veerapol Kukongviriyapan1, Nuntiya Somparn, Laddawan Senggunprai, Auemduan Prawan, Upa Kukongviriyapan, Arunee Jetsrisuparb.   

Abstract

Thalassemia major is characterized by anemia, iron overload, and oxidant damage to major organs, especially the cardiovascular system. Oxidative stress is ultimately involved in endothelial dysfunction, a condition which is evident in adults suffering from various cardiovascular diseases including thalassemia. We investigated endothelial function in pediatric patients with hemoglobin E-beta thalassemia (HbE-beta thalassemia), who have been exposed to excessive iron and oxidative stress for much shorter period than adults with thalassemia. We recruited 22 blood transfusion-dependent HbE-beta thalassemia patients aged 11.8 +/- 2.9 years and 20 healthy controls aged 12.1 +/- 1.7 years. Oxidant status was determined, and endothelial function was assessed by a forearm blood flow technique. Oxidative stress was increased in the thalassemic patients, as blood glutathione (GSH) and ratios of reduced GSH to GSH disulfide were markedly reduced, and superoxide anion released from blood cells was highly elevated. Oxidative stress response, assessed by gamma-glutamylcysteine ligase activity, was increased approximately twofold in thalassemia patients. Basal forearm blood flow was significantly increased in patients compared with controls (7.3 +/- 1.8 vs 6.0 +/- 1.8 ml/100 ml tissue/min, respectively), whereas forearm vasodilatory response to reactive hyperemia was depressed by 50% in patients compared with controls. Endothelial function is impaired in young thalassemia patients, and impaired endothelial function is associated with oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891513     DOI: 10.1007/s00246-007-9107-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  29 in total

Review 1.  Pathophysiology of thalassaemia.

Authors:  D J Weatherall
Journal:  Baillieres Clin Haematol       Date:  1998-03

2.  Endothelial function in patients with sickle cell anemia during and after sickle cell crises.

Authors:  Arnon Blum; Shay Yeganeh; Aviva Peleg; Fina Vigder; Konstantin Kryuger; Ahmed Khatib; Khalid Khazim; Harold Dauerman
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

3.  Early onset of endocrine abnormalities in beta-thalassemia major in a developing country.

Authors:  R Gulati; V Bhatia; S S Agarwal
Journal:  J Pediatr Endocrinol Metab       Date:  2000-06       Impact factor: 1.634

4.  Elevated polymorphonuclear phagocytic function in thalassemia patients by chemiluminescence.

Authors:  S S Deo; S M Merchant; A C Kapadia
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

5.  Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.

Authors:  Y Higashi; S Sasaki; K Nakagawa; H Matsuura; G Kajiyama; T Oshima
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

6.  The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major.

Authors:  F Centis; L Tabellini; G Lucarelli; O Buffi; P Tonucci; B Persini; M Annibali; R Emiliani; A Iliescu; S Rapa; R Rossi; L Ma; E Angelucci; S L Schrier
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Authors:  Caterina Borgna-Pignatti; Simone Rugolotto; Piero De Stefano; Huaqing Zhao; Maria Domenica Cappellini; Giovanni Carlo Del Vecchio; Maria Antonietta Romeo; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Avital Cnaan
Journal:  Haematologica       Date:  2004-10       Impact factor: 9.941

8.  Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite.

Authors:  C P Verdon; B A Burton; R L Prior
Journal:  Anal Biochem       Date:  1995-01-20       Impact factor: 3.365

Review 9.  Reactive oxygen species in the vasculature: molecular and cellular mechanisms.

Authors:  Yoshihiro Taniyama; Kathy K Griendling
Journal:  Hypertension       Date:  2003-10-27       Impact factor: 10.190

10.  Labile plasma iron in iron overload: redox activity and susceptibility to chelation.

Authors:  Breno P Esposito; William Breuer; Pornpan Sirankapracha; Pensri Pootrakul; Chaim Hershko; Z Ioav Cabantchik
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

View more
  17 in total

1.  Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia.

Authors:  Supeenun Unchern; Narumon Laohareungpanya; Yupin Sanvarinda; Kovit Pattanapanyasat; Pansakorn Tanratana; Udom Chantharaksri; Nathawut Sibmooh
Journal:  Lipids       Date:  2010-06-09       Impact factor: 1.880

2.  Consumption of Syzygium gratum promotes the antioxidant defense system in mice.

Authors:  Laddawan Senggunprai; Veerapol Kukongviriyapan; Auemduan Prawan; Upa Kukongviriyapan
Journal:  Plant Foods Hum Nutr       Date:  2010-12       Impact factor: 3.921

3.  Blockade of angiotensin AT1 receptors prevents arterial remodelling and stiffening in iron-overloaded rats.

Authors:  Helbert Gabriel Fidelis; Jandinay Gonzaga Alexandre Mageski; Susana Curry Evangelista Goes; Tatiani Botelho; Vinicius Bermond Marques; Renata Andrade Ávila; Leonardo Dos Santos
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

4.  Diagnosis of Systemic Diseases Using Infrared Spectroscopy: Detection of Iron Overload in Plasma-Preliminary Study.

Authors:  Leonardo Barbosa Leal; Marcelo Saito Nogueira; Jandinay Gonzaga Alexandre Mageski; Thiago Pereira Martini; Valério Garrone Barauna; Leonardo Dos Santos; Luis Felipe das Chagas E Silva de Carvalho
Journal:  Biol Trace Elem Res       Date:  2021-01-07       Impact factor: 3.738

5.  Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension.

Authors:  Saowanee Nakmareong; Upa Kukongviriyapan; Poungrat Pakdeechote; Wanida Donpunha; Veerapol Kukongviriyapan; Bunkerd Kongyingyoes; Kwanjit Sompamit; Chada Phisalaphong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

6.  Altered vascular function, arterial stiffness, and antioxidant gene responses in pediatric thalassemia patients.

Authors:  Pantipa Detchaporn; Upa Kukongviriyapan; Auemduan Prawan; Arunee Jetsrisuparb; Stephen E Greenwald; Veerapol Kukongviriyapan
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

7.  Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in β-thalassemia/HbE patients.

Authors:  Sudarat Satitthummanid; Noppacharn Uaprasert; Smonporn Boonyaratavej Songmuang; Ponlapat Rojnuckarin; Piyaratana Tosukhowong; Pranee Sutcharitchan; Suphot Srimahachota
Journal:  Int J Hematol       Date:  2017-05-04       Impact factor: 2.490

8.  Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.

Authors:  Byeong Hyeok Ye; Seung Jin Lee; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

9.  Structural and functional studies indicating altered redox properties of hemoglobin E: implications for production of bioactive nitric oxide.

Authors:  Camille J Roche; Vladimir Malashkevich; Tatiana C Balazs; David Dantsker; Qiuying Chen; Juan Moreira; Steven C Almo; Joel M Friedman; Rhoda Elison Hirsch
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

Review 10.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.